Is BMY stock safe? | Glauxie AI

Q: Is BMY stock safe?

Bristol-Myers Squibb Company (BMY) operates in the Drug Manufacturers - General industry (Healthcare sector). The company is led by CEO Christopher S. Boerner. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology,... Employees: 32,500.

Q: What are the risks of investing in BMY?

Identify key risks of investing in BMY — debt, competition, volatility, and sector headwinds.

Q: Is BMY a good long-term investment?

Evaluate BMY as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does BMY have?

Review BMY total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is BMY stock safe?

🦉

Bristol-Myers Squibb Company (BMY)

Company Overview

Sector / IndustryHealthcare / Drug Manufacturers - General

CEOChristopher S. Boerner

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral...

Key Executives

Name	Title
Adam Lenkowsky	Executive Vice President & Chief Commercialization Officer
Ahn Amanda Poole	Executive Vice President & Chief People Officer
Cari Gallman	Executive Vice President, General Counsel & Chief Policy Officer
Charles E. Triano	SVP & Head of Investor Relations
Christopher S. Boerner	Chief Executive Officer & Chairman
Cristian Massacesi	Executive Vice President, Chief Medical Officer & Head of Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

BMY Profile Financials

What are the risks of investing in BMY? Is BMY a good long-term investment? How much debt does BMY have?